# LORAZEPAM
> **ANDA217598** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2024-11-18
## Drug
- **FDA Application Number:** ANDA217598
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LORAZEPAM
- **Generic name:** LORAZEPAM
- **Active ingredients:** LORAZEPAM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2024-11-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217598)
---
*AI Analytics · CC0 1.0*